Guidelines for the pharmacological acute treatment of major depression: conflicts with current evidence as demonstrated with the German S3-guidelines

Considering the methodological limitations in the evidence base of antidepressants for depression: a reanalysis of a network meta-analysis

(2019) Klaus Munkholm et al.   BMJ Open

Initial severity of major depression and efficacy of new generation antidepressants: individual participant data meta-analysis

(2018) T. A. Furukawa et al.   ACTA PSYCHIATRICA SCANDINAVICA

The comparative evidence basis for the efficacy of second-generation antidepressants in the treatment of depression in the US: A Bayesian meta-analysis of Food and Drug Administration reviews

(2018) Rei Monden et al.   JOURNAL OF AFFECTIVE DISORDERS

Impact of demographic factors on the antidepressant effect: A patient-level data analysis from depression trials submitted to the Pharmaceuticals and Medical Devices Agency in Japan

(2018) Tetsuo Nakabayashi et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis

(2018) Andrea Cipriani et al.   LANCET

Effectiveness of antidepressants

(2018) James McCormack et al.   BMJ-British Medical Journal

Effectiveness of antidepressants

(2018) James McCormack et al.   BMJ-British Medical Journal

The cumulative effect of reporting and citation biases on the apparent efficacy of treatments: the case of depression

(2018) Y. A. de Vries et al.   PSYCHOLOGICAL MEDICINE

Professional Societies Should Abstain From Authorship of Guidelines and Disease Definition Statements

(2018) John P.A. Ioannidis  

Statistically Significant Antidepressant-Placebo Differences on Subjective Symptom-Rating Scales Do Not Prove That the Drugs Work: Effect Size and Method Bias Matter!

(2018) Michael P. Hengartner et al.   Frontiers in Psychiatry

Efficacy of antidepressants: bias in randomized clinical trials and related issues

(2017) Sheng-Min Wang et al.   Expert Review of Clinical Pharmacology

Methodological Flaws, Conflicts of Interest, and Scientific Fallacies: Implications for the Evaluation of Antidepressants’ Efficacy and Harm

(2017) Michael P. Hengartner   Frontiers in Psychiatry

Initial depression severity and response to antidepressants v. placebo: patient-level data analysis from 34 randomised controlled trials

(2016) Jonathan Rabinowitz et al.   BRITISH JOURNAL OF PSYCHIATRY

Melancholic and atypical depression as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression

(2016) Pim Cuijpers et al.   DEPRESSION AND ANXIETY

An overview of methods for network meta-analysis using individual participant data: when do benefits arise?

(2016) Thomas PA Debray et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

Comparative Benefits and Harms of Antidepressant, Psychological, Complementary, and Exercise Treatments for Major Depression: An Evidence Report for a Clinical Practice Guideline From the American College of Physicians

(2015) Gerald Gartlehner et al.   ANNALS OF INTERNAL MEDICINE

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

(2015) Gin S Malhi et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

The STAR*D Trial: It is Time to Reexamine the Clinical Beliefs That Guide the Treatment of Major Depression

(2015) H Edmund Pigott   CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor

(2015) Maria Elena Flacco et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Baseline Depression Severity as Moderator of Depression Outcomes Between Cognitive Behavioral Therapy vs Pharmacotherapy

(2015) Erica S. Weitz et al.   JAMA Psychiatry

Declining efficacy in controlled trials of antidepressants: effects of placebo dropout

(2014) Stein Schalkwijk et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Moderators of Outcome in Late-Life Depression: A Patient-Level Meta-Analysis

(2013) J. Craig Nelson et al.   AMERICAN JOURNAL OF PSYCHIATRY

Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors

(2013) A. Hrobjartsson et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Randomized, Placebo-Controlled Trials of Antidepressants for Acute Major Depression: Thirty-Year Meta-Analytic Review

(2011) Juan Undurraga et al.   NEUROPSYCHOPHARMACOLOGY

Antidepressant Drug Effects and Depression Severity

(2010) Jay C. Fournier et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Antidepressant–placebo differences in 16 clinical trials over 10 years at a single site: role of baseline severity

(2010) Arif Khan et al.   PSYCHOPHARMACOLOGY

The clinical significance of antidepressant treatment effects cannot be derived from placebo-verum response differences

(2009) U. Hegerl et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Isn’t the efficacy of antidepressants clinically relevant? A critical comment on the results of the metaanalysis by Kirsch et al. 2008

(2008) Hans Jürgen Möller   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

A regulatory Apologia — A review of placebo-controlled studies in regulatory submissions of new-generation antidepressants

(2008) Hans Melander et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

(2008) Erick H. Turner et al.   NEW ENGLAND JOURNAL OF MEDICINE

Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration

(2008) Irving Kirsch et al.   PLOS MEDICINE